Sachet Ashok Shukla

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0003-2445-3584

发表论文 276 篇 · 总被引 52356 次 · h-index 54

代表论文

• PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia (2025 · Blood Cancer Discovery · 被引 2)
• Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma (2026 · Clinical Cancer Research)
• Abstract 1495: A novel, deep learning -based filtering tool for enhanced detection of technical artifacts in whole-genome sequencing data (2026 · Cancer Research)
• Abstract 3075: FGFR2b is a highly prevalent and actionable cell surface target in intrahepatic cholangiocarcinoma (2026 · Cancer Research)
• Abstract PR001: Exploiting HIF-driven endogenous retroviral neoantigens to advance kidney cancer immunotherapy (2026 · Cancer Research)
• Supplementary Figure S8 from PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia (2026)